291 related articles for article (PubMed ID: 38194742)
1. Phylogenomic early warning signals for SARS-CoV-2 epidemic waves.
Drake KO; Boyd O; Franceschi VB; Colquhoun RM; Ellaby NAF; Volz EM
EBioMedicine; 2024 Feb; 100():104939. PubMed ID: 38194742
[TBL] [Abstract][Full Text] [Related]
2. An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients.
Gonçalves BP; Hall M; Jassat W; Balan V; Murthy S; Kartsonaki C; Semple MG; Rojek A; Baruch J; Reyes LF; Dasgupta A; Dunning J; Citarella BW; Pritchard M; Martín-Quiros A; Sili U; Baillie JK; Aryal D; Arabi Y; Rashan A; Angheben A; Caoili J; Carrier FM; Harrison EM; Gómez-Junyent J; Figueiredo-Mello C; Douglas JJ; Mat Nor MB; Chow YP; Wong XC; Bertagnolio S; Thwin SS; Streinu-Cercel A; Salazar L; Rishu A; Rangappa R; Ong DSY; Hashmi M; Carson G; Diaz J; Fowler R; Kraemer MUG; Wils EJ; Horby P; Merson L; Olliaro PL;
Elife; 2022 Oct; 11():. PubMed ID: 36197074
[TBL] [Abstract][Full Text] [Related]
3. Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies.
Cheetham NJ; Kibble M; Wong A; Silverwood RJ; Knuppel A; Williams DM; Hamilton OKL; Lee PH; Bridger Staatz C; Di Gessa G; Zhu J; Katikireddi SV; Ploubidis GB; Thompson EJ; Bowyer RCE; Zhang X; Abbasian G; Garcia MP; Hart D; Seow J; Graham C; Kouphou N; Acors S; Malim MH; Mitchell RE; Northstone K; Major-Smith D; Matthews S; Breeze T; Crawford M; Molloy L; Kwong ASF; Doores K; Chaturvedi N; Duncan EL; Timpson NJ; Steves CJ
Elife; 2023 Jan; 12():. PubMed ID: 36692910
[TBL] [Abstract][Full Text] [Related]
4. Transmission networks of SARS-CoV-2 in Coastal Kenya during the first two waves: A retrospective genomic study.
Agoti CN; Ochola-Oyier LI; Dellicour S; Mohammed KS; Lambisia AW; de Laurent ZR; Morobe JM; Mburu MW; Omuoyo DO; Ongera EM; Ndwiga L; Maitha E; Kitole B; Suleiman T; Mwakinangu M; Nyambu JK; Otieno J; Salim B; Musyoki J; Murunga N; Otieno E; Kiiru JN; Kasera K; Amoth P; Mwangangi M; Aman R; Kinyanjui S; Warimwe G; Phan M; Agweyu A; Cotten M; Barasa E; Tsofa B; Nokes DJ; Bejon P; Githinji G
Elife; 2022 Jun; 11():. PubMed ID: 35699426
[TBL] [Abstract][Full Text] [Related]
5. Tracking SARS-CoV-2 introductions in Mozambique using pandemic-scale phylogenies: a retrospective observational study.
Martínez-Martínez FJ; Massinga AJ; De Jesus Á; Ernesto RM; Cano-Jiménez P; Chiner-Oms Á; Gómez-Navarro I; Guillot-Fernández M; Guinovart C; Sitoe A; Vubil D; Bila R; Gujamo R; Enosse S; Jiménez-Serrano S; Torres-Puente M; Comas I; Mandomando I; López MG; Mayor A
Lancet Glob Health; 2023 Jun; 11(6):e933-e941. PubMed ID: 37202028
[TBL] [Abstract][Full Text] [Related]
6. Genomic epidemiology of SARS-CoV-2 infections in The Gambia: an analysis of routinely collected surveillance data between March, 2020, and January, 2022.
Kanteh A; Jallow HS; Manneh J; Sanyang B; Kujabi MA; Ndure SL; Jarju S; Sey AP; Damilare K D; Bah Y; Sambou S; Jarju G; Manjang B; Jagne A; Bittaye SO; Bittaye M; Forrest K; Tiruneh DA; Samateh AL; Jagne S; Hué S; Mohammed N; Amambua-Ngwa A; Kampmann B; D'Alessandro U; de Silva TI; Roca A; Sesay AK
Lancet Glob Health; 2023 Mar; 11(3):e414-e424. PubMed ID: 36796985
[TBL] [Abstract][Full Text] [Related]
7. Repurposing an integrated national influenza platform for genomic surveillance of SARS-CoV-2 in Ghana: a molecular epidemiological analysis.
Asante IA; Hsu SN; Boatemaa L; Kwasah L; Adusei-Poku M; Odoom JK; Awuku-Larbi Y; Foulkes BH; Oliver-Commey J; Asiedu EK; Parker MD; Mitja O; Eggo RM; de Oliveira-Martins L; Asiedu-Bekoe F; Laryea DO; Kuma-Aboagye P; Marks M; de Silva TI; Ampofo WK
Lancet Glob Health; 2023 Jul; 11(7):e1075-e1085. PubMed ID: 37349034
[TBL] [Abstract][Full Text] [Related]
8. Unraveling the Dynamics of Omicron (BA.1, BA.2, and BA.5) Waves and Emergence of the Deltacton Variant: Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus (Oct 2021-Oct 2022).
Chrysostomou AC; Vrancken B; Haralambous C; Alexandrou M; Gregoriou I; Ioannides M; Ioannou C; Kalakouta O; Karagiannis C; Marcou M; Masia C; Mendris M; Papastergiou P; Patsalis PC; Pieridou D; Shammas C; Stylianou DC; Zinieri B; Lemey P; The Comessar Network ; Kostrikis LG
Viruses; 2023 Sep; 15(9):. PubMed ID: 37766339
[TBL] [Abstract][Full Text] [Related]
9. Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants.
Blanquart F; Hozé N; Cowling BJ; Débarre F; Cauchemez S
Elife; 2022 May; 11():. PubMed ID: 35587653
[TBL] [Abstract][Full Text] [Related]
10. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 clade dynamics and their associations with hospitalisations during the first two years of the COVID-19 pandemic.
Päll T; Abroi A; Avi R; Niglas H; Shablinskaja A; Pauskar M; Jõgeda EL; Soeorg H; Kallas E; Lahesaare A; Truusalu K; Hoidmets D; Sadikova O; Ratnik K; Sepp H; Dotsenko L; Epštein J; Suija H; Kaarna K; Smit S; Milani L; Metspalu M; Oopkaup OE; Koppel I; Jaaniso E; Kuzmin I; Inno H; Raudvere U; Härma MA; Naaber P; Reisberg T; Peterson H; Talas UG; Lutsar I; Huik K
PLoS One; 2024; 19(5):e0303176. PubMed ID: 38728305
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
13. Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
Sonabend R; Whittles LK; Imai N; Perez-Guzman PN; Knock ES; Rawson T; Gaythorpe KAM; Djaafara BA; Hinsley W; FitzJohn RG; Lees JA; Kanapram DT; Volz EM; Ghani AC; Ferguson NM; Baguelin M; Cori A
Lancet; 2021 Nov; 398(10313):1825-1835. PubMed ID: 34717829
[TBL] [Abstract][Full Text] [Related]
14. Wastewater Genomic Surveillance Captures Early Detection of Omicron in Utah.
Gupta P; Liao S; Ezekiel M; Novak N; Rossi A; LaCross N; Oakeson K; Rohrwasser A
Microbiol Spectr; 2023 Jun; 11(3):e0039123. PubMed ID: 37154725
[TBL] [Abstract][Full Text] [Related]
15. Analysis of SARS-CoV-2 genomic surveillance data during the Delta and Omicron waves at a Saudi tertiary referral hospital.
Obeid D; Al-Qahtani A; Almaghrabi R; Alghamdi S; Alsanea M; Alahideb B; Almutairi S; Alsuwairi F; Al-Abdulkareem M; Asiri M; Alshukairi A; Alkahtany J; Altamimi S; Mutabagani M; Althawadi S; Alanzi F; Alhamlan F
J Infect Public Health; 2023 Feb; 16(2):171-181. PubMed ID: 36543031
[TBL] [Abstract][Full Text] [Related]
16. A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.
Anisul M; Shilts J; Schwartzentruber J; Hayhurst J; Buniello A; Shaikho Elhaj Mohammed E; Zheng J; Holmes M; Ochoa D; Carmona M; Maranville J; Gaunt TR; Emilsson V; Gudnason V; McDonagh EM; Wright GJ; Ghoussaini M; Dunham I
Elife; 2021 Aug; 10():. PubMed ID: 34402426
[TBL] [Abstract][Full Text] [Related]
17. Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populations.
Canas LS; Molteni E; Deng J; Sudre CH; Murray B; Kerfoot E; Antonelli M; Rjoob K; Capdevila Pujol J; Polidori L; May A; Österdahl MF; Whiston R; Cheetham NJ; Bowyer V; Spector TD; Hammers A; Duncan EL; Ourselin S; Steves CJ; Modat M
Lancet Digit Health; 2023 Jul; 5(7):e421-e434. PubMed ID: 37202336
[TBL] [Abstract][Full Text] [Related]
18. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
COVID-19 Cumulative Infection Collaborators
Lancet; 2022 Jun; 399(10344):2351-2380. PubMed ID: 35405084
[TBL] [Abstract][Full Text] [Related]
19. Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study.
Eyre DW; Futschik M; Tunkel S; Wei J; Cole-Hamilton J; Saquib R; Germanacos N; Dodgson AR; Klapper PE; Sudhanva M; Kenny C; Marks P; Blandford E; Hopkins S; Peto TEA; Fowler T
Lancet Infect Dis; 2023 Aug; 23(8):922-932. PubMed ID: 37001541
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
